5 pharmaceuticals for the relief of pain and treatment of palliative care, nausea and vomiting, wasting syndrome and loss of appetite in AIDS and cancer patients, anorexia nervosa, multiple sclerosis, amyotrophic lateral sclerosis, spinal cord injury, epilepsy, pain, arthritis, neuromuscular diseases and disorders, namely, cerebrovascular accident (stroke), Parkinson's disease, multiple sclerosis, myasthenia gravis, Huntington's disease, amyotrophic lateral sclerosis, spinal cord injury, epilepsy, and pain, movement disorders, glaucoma, asthma, hypertension, mental illness, namely, anxiety, depression, sleep disorders, post-traumatic stress disorder, alcohol and opioid withdrawal symptoms, schizophrenia and psychosis, Alzheimer's disease, and dementia, inflammatory diseases, namely, inflammatory skin diseases, gastrointestinal system disorders, irritable bowel syndrome, and inflammatory bowel diseases, diseases of the liver, metabolic syndrome, obesity, diabetes, diseases of the pancreas, anti-neoplastic properties, and atherosclerosis; pharmaceuticals containing one or more cannabinoids as the active ingredient; pharmaceuticals, nutraceuticals and consumer products containing cannabis, cannabinoids or cannabis compounds; cannabinoids or cannabis compounds for use in pharmaceuticals; cannabis compounds, namely, medicines containing a tetrahydrocannabinol extract; cannabis based pharmaceuticals and nutraceuticals; narcotics for medical use; nutritional and dietary supplements for general health and well-being; pharmaceutical preparations for the relief of pain and treatment of palliative care, nausea and vomiting, wasting syndrome and loss of appetite in AIDS and cancer patients, anorexia nervosa, multiple sclerosis, amyotrophic lateral sclerosis, spinal cord injury, epilepsy, pain, arthritis, neuromuscular diseases and disorders, namely, cerebrovascular accident (stroke), Parkinson's disease, multiple sclerosis, myasthenia gravis, Huntington's disease, amyotrophic lateral sclerosis, spinal cord injury, epilepsy, and pain, movement disorders, glaucoma, asthma, hypertension, mental illness, namely, anxiety, depression, sleep disorders, post-traumatic stress disorder, alcohol and opioid withdrawal symptoms, schizophrenia and psychosis, Alzheimer's disease, and dementia, inflammatory diseases, namely, inflammatory skin diseases, gastrointestinal system disorders, irritable bowel syndrome, and inflammatory bowel diseases, diseases of the liver, metabolic syndrome, obesity, diabetes, diseases of the pancreas, anti-neoplastic properties, and atherosclerosis; pharmaceutical preparations containing one or more cannabinoids as the active ingredient; medicines containing a tetrahydrocannabinol extract; medicines derived from cannabis; nutraceuticals, plants, dried plant material, seeds and medicines derived from the cannabis plant; products, plants, dried plant material, seeds and medicines derived from and/or related to the cannabis plant, namely, anti-inflammatories, analgesics, sedatives, appetite stimulants, anti-nauseants, intraocular pressure reducers, anti-tumors, antioxidants, antidepressants and antihypertensives
Trademark: 88051051
